| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/05/2007 | WO2007038171A2 Peptide nucleic acid based guanidinium compounds |
| 04/05/2007 | WO2007038110A2 Trans-lutein xantophyllester of high purity and bioavailability in micellar solution |
| 04/05/2007 | WO2007037849A2 Compositions and methods for the intraocular transport of therapeutic agents |
| 04/05/2007 | WO2007037444A1 Vector for delivering target substance into nucleus or cell |
| 04/05/2007 | WO2007037330A1 Method for production of quinolone-containing lyophilized preparation |
| 04/05/2007 | WO2007037273A1 Introduction of substance into cell by using nanoparticle having cell membrane-permeable peptide displayed thereon |
| 04/05/2007 | WO2007037259A1 Pulse preparation having improved disintegration properties in vivo |
| 04/05/2007 | WO2007037249A1 Cellooligosaccharide-containing composition |
| 04/05/2007 | WO2007037069A1 Particle for medical use and process for producing the same |
| 04/05/2007 | WO2007036632A1 Orodispersible tablets of bitter active principles |
| 04/05/2007 | WO2007036376A2 Skincare products |
| 04/05/2007 | WO2007036278A2 Method for stabilising pharmaceutical administration forms that contain micro-organisms |
| 04/05/2007 | WO2007036022A1 Targeted delivery of compounds using multimerization technology |
| 04/05/2007 | WO2007016562A3 Formulations that inhibit protein aggregation |
| 04/05/2007 | WO2007010430A3 Pharmaceutical composition for treating xerostomia |
| 04/05/2007 | WO2007005358A3 Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 04/05/2007 | WO2006128742A3 Treatment and pre-treatment device, and manufacturing method therefor, involving nitric oxide |
| 04/05/2007 | WO2006108405B1 Nanoparticle/active ingredient conjugate |
| 04/05/2007 | WO2006106435A3 Fusion protein comprising a hiv nef double mutant and its use therapy |
| 04/05/2007 | WO2006100075A3 Use of an artificial sweetener to enhance absorption of nicotine |
| 04/05/2007 | WO2006073419A3 Lipoprotein nanoplatforms |
| 04/05/2007 | WO2006043005A3 Bioadhesive composition with programmed release |
| 04/05/2007 | WO2006037979A3 Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| 04/05/2007 | WO2006025767A8 Perorally administrable antimicrobial composition |
| 04/05/2007 | WO2004016799A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 04/05/2007 | WO2003070751A3 Partial peptide mimetics and methods |
| 04/05/2007 | US20070078522 Particulate Acellular Tissue Matrix |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078103 Formulations comprising antisense nucleotides to connexins |
| 04/05/2007 | US20070078096 Buffered drug formulations for transdermal electrotransport delivery |
| 04/05/2007 | US20070078092 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/05/2007 | US20070078084 Compositions and methods related to production of erythropoietin |
| 04/05/2007 | US20070078076 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 04/05/2007 | US20070077432 Finely particulate composite containing carbon compound encapsulated therein |
| 04/05/2007 | US20070077289 Cream containing interferon encapsulated with liposome |
| 04/05/2007 | US20070077288 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 04/05/2007 | US20070077278 Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
| 04/05/2007 | US20070077277 Compositions and uses thereof |
| 04/05/2007 | US20070077273 Microfabricated nanopore device for sustained release of therapeutic agent |
| 04/05/2007 | US20070077266 Drug/gene eluting stent |
| 04/05/2007 | US20070077248 Tumour necrosis factor binding ligands |
| 04/05/2007 | US20070077239 Peptide carrier for drug delivery |
| 04/05/2007 | US20070077209 Stabilized particle dispersions containing nanoparticles |
| 04/05/2007 | US20070077207 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | CA2850858A1 Compositions and methods for the intraocular transport of therapeutic agents |
| 04/05/2007 | CA2624494A1 Orodispersible tablets of bitter active principles |
| 04/05/2007 | CA2624356A1 Skincare products |
| 04/05/2007 | CA2624047A1 Kit for parenteral administration of lipophilic drug solutions |
| 04/05/2007 | CA2623968A1 Method for stabilising pharmaceutical administration forms comprising microorganisms |
| 04/05/2007 | CA2623678A1 Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride |
| 04/05/2007 | CA2623659A1 Targeted delivery of compounds using multimerization technology |
| 04/05/2007 | CA2623652A1 Antibody-drug conjugates and methods of use |
| 04/05/2007 | CA2623429A1 Interleukin-13 antibody composition |
| 04/05/2007 | CA2623418A1 Use of a polyphenol extract of grape for lowering blood pressure in a subject suffering from metabolic syndrome or pre-hypertension |
| 04/05/2007 | CA2623387A1 Use of ephrinb2 directed agents for the treatment or prevention of viral infections |
| 04/05/2007 | CA2622002A1 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear |
| 04/05/2007 | CA2618068A1 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 04/05/2007 | CA2602440A1 Compositions and methods for the intraocular transport of therapeutic agents |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1769806A2 Vaccine against HPV |
| 04/04/2007 | EP1769785A1 Dermal penetration enhancers and drug delivery systems involving same |
| 04/04/2007 | EP1769065A1 Vaccine composition against rhodococcus equi |
| 04/04/2007 | EP1768707A2 Cellular receptors utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 04/04/2007 | EP1768701A2 Carrier for medicaments for obtaining oral bioavailability |
| 04/04/2007 | EP1768692A2 Targeted and high density drug loaded polymeric materials |
| 04/04/2007 | EP1768686A2 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 04/04/2007 | EP1768499A1 Medicinal products incorporating bound organosulfur groups |
| 04/04/2007 | EP1768491A1 Methods and compositions for controlling parasitic infections of animals |
| 04/04/2007 | EP1395254B1 Oral pharmaceutical composition containing a statin derivative |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1325757B1 Embolic materials |
| 04/04/2007 | EP1296658B1 Use of an acetylated pre-gelled starch with a high content of amylose |
| 04/04/2007 | EP1029548B1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942478A Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
| 04/04/2007 | CN1942476A Regiospecific synthesis of rapamycin 42-ester derivatives |
| 04/04/2007 | CN1942207A Crosslinkable skin care adhesive |
| 04/04/2007 | CN1942197A Method for improved breast milk feeding to reduce the risk of allergy |
| 04/04/2007 | CN1942183A Isosorbide-containing jelly preparation |
| 04/04/2007 | CN1942181A Tablet containing branched chain amino acid and process for producing the same |
| 04/04/2007 | CN1942173A Solid pharmaceutical preparation with improved stability and process for producing the same |
| 04/04/2007 | CN1942171A Liquids containing suspended glass particles |
| 04/04/2007 | CN1939919A Low-toxic and broad-spectrum phthalocyanine bactericide, its production and use |
| 04/04/2007 | CN1939528A Ginger-fluid extract drop pills and production thereof |
| 04/04/2007 | CN1939505A Shengmai drop pill and its production |
| 04/04/2007 | CN1939406A Danshen root drop pills for treating coronary heart disease and preparation thereof |
| 04/04/2007 | CN1939399A Blood stream-breaking dispersing tablets |
| 04/04/2007 | CN1939388A Kudzuvine root extract drop balls and preparation thereof |
| 04/04/2007 | CN1939369A Ginseng saponin drop balls and making method thereof |
| 04/04/2007 | CN1939362A Common andrographis herb drop balls and preparation thereof |
| 04/04/2007 | CN1939361A Patrinia scaniosaefolia dropping balls and preparation thereof |
| 04/04/2007 | CN1939349A Improvement of pelletization in Chinese medicine prescription by dry method |
| 04/04/2007 | CN1939343A Bone-peptide sodium chloride injection and its making method |
| 04/04/2007 | CN1939316A Microsphere containing adriamycin, its usage and preparation |
| 04/04/2007 | CN1939314A Ibandronic acid for the treatment and prevention of osteoporosis |
| 04/04/2007 | CN1939305A Cephalofruxin ester liposome, its preparation and medicinal composition containing it |
| 04/04/2007 | CN1939303A Novel composition and use. |
| 04/04/2007 | CN1939300A Oral preparation containing amocillin and its making method |
| 04/04/2007 | CN1939293A Naprosyn alginic aid calcium gel microsphere preparation and its making method |